Substance

ID:478

Names and Identifiers
Brand Name
Oxytetracycline HClOxytetracycline anhydrousTerramycin
IUPAC name
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
Synonyms
Oxytetracycline
IUPAC Traditional name
oxytetracycline
Registration numbers
PubChem CID
CAS Number
PubChem SID
Properties
Physical Property
Solubility
0.6 mg/mL (6.9 mg/mL as HCl salt)
Hydrophobicity(logP)
-1.3
Molecule Details
Drug Groups
approved
Description
A tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. [PubChem]
Indication
Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.
Pharmacology
Oxytetracycline is known as a broad-spectrum antibiotic due to its activity against such a wide range of infections. It was the second of the tetracyclines to be discovered. Oxytetracycline, like other tetracyclines, is used to treat many infections common and rare. Its better absorption profile makes it preferable to tetracycline for moderately severe acne, but alternatives sould be sought if no improvement occurs by 3 months.
Toxicity
Adverse effects may include stomach or bowel upsets and rarely allergic reactions. Very rarely severe headache and vision problems may be signs of dangerous intracranial hypertenion.
Affected Organisms
Enteric bacteria and other eubacteria
Absorption
Readily absorbed following oral administration.
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data